Showing results (1501-1510 of 1,728) with videos related to
Sort By:
Pageof 173
Annals of the New York Academy of Sciences|January 1, 1991
Contribution of leukotriene B4 to airway inflammation and the effect of antagonistsI M Richards, F F Sun, B M Taylor, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|January 31, 2007
D-Penicillamine administration and the incidence of retinopathy of prematurityR D Christensen, S C Alder, S C Richards, et al.Pediatrics|December 1, 1982
Prolonged apnea and cardiac arrhythmias in infants discharged from neonatal intensive care units: failure to predict an increased risk for sudden infant death syndromeD P Southall, J M Richards, K J Rhoden, et al.Cancer Research|July 5, 2002
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau diseaseMalgorzata Zatyka, Nancy Fernandes da Silva, Steven C Clifford, et al.Journal of Cardiovascular Electrophysiology|October 12, 2011
KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patientsBarry R Palmer, C M Frampton, Lorraine Skelton, et al.Ebiomedicine|May 28, 2021
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approachTimothy I Johnson, Christopher J Minteer, Daniel Kottmann, et al.Frontiers in Oncology|December 16, 2022
Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patientsAgnes Reschke, Rebecca M Richards, Stephanie M Smith, et al.Journal of the American College of Surgeons|July 11, 1998
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trialM K Wallack, M Sivanandham, C M Balch, et al.British Journal of Cancer|March 2, 2013
A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumoursM A Warso, J M Richards, D Mehta, et al.British Journal of Cancer|May 31, 2014
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivoT E Bapiro, K K Frese, A Courtin, et al.Pageof 173